Your browser is no longer supported. Please, upgrade your browser.
PMR Invesco Dynamic Retail ETF daily Stock Chart
Invesco Dynamic Retail ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-0.79%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month8.90%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter8.86%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio2.06 Perf Half Y14.50%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year11.46%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range32.00 - 40.81 Perf YTD7.20%
Dividend0.45 P/FCF- EPS past 5Y- ROI- 52W High-2.29% Beta-
Dividend %1.13% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low24.63% ATR0.35
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)71.28 Volatility0.30% 0.43%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.62 Prev Close39.88
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume1.02K Price39.88
Recom- SMA203.76% SMA507.59% SMA20011.02% Volume0 Change0.00%
Jun-11-18 03:23PM  Best Sector ETFs of Last Week Zacks
08:30AM  PharmaMar Signs a Commercialization and Distribution License Agreement for Aplidin® With Pint Pharma International PR Newswire
Jun-06-18 03:13PM  Here's Why the Rally in Retail ETFs Will Continue in 2H Zacks
Jun-05-18 08:30AM  PharmaMar Presents in Oral Session at ASCO: The ADMYRE Study's Adjusted Overall Survival With Plitidepsin PR Newswire
Jun-04-18 08:30AM  PharmaMar Presents New Results with Lurbinectedin as a Single Agent in Patients with Recurrent Small-cell Lung Cancer at ASCO 2018 PR Newswire
May-29-18 08:01PM  Winners and Losers in Small-Cap Retail Harvest Exchange
08:30AM  Positive Recommendation of IDMC to Zepsyre® to Continue the Phase III Trial Within Small-cell Lung Cancer (ATLANTIS) PR Newswire
May-17-18 08:30AM  PharmaMar Announces Data Presentations For Both Its Molecules Yondelis® and Lurbinectedin at ASCO 2018 PR Newswire
May-07-18 08:30AM  Sylentis Announces New Data on the Treatment of Allergic Conjunctivitis PR Newswire
May-03-18 08:30AM  Sylentis Announces the Clinical Results of Tivanisiran for the Treatment of Dry Eye Syndrome PR Newswire
Apr-26-18 08:30AM  Sylentis Presents New Results on Its Ophthalmological Compounds at ARVO 2018 PR Newswire
Mar-26-18 08:30AM  PharmaMar Announces Participation at the 17th Needham & Co Annual Healthcare Conference in New York City PR Newswire
Feb-14-18 10:10AM  Discretionary ETFs to Splurge on This Valentine's Day Zacks
08:30AM  PharmaMar Licenses Fully Synthetic Marine-derived Payloads to Seattle Genetics for Use in Drug Conjugates PR Newswire
Jan-25-18 09:55AM  4 ETFs Set to Surge Amid Q4 Earnings InvestorPlace
Jan-03-18 08:30AM  PharmaMar has Requested the Process of Re-Examination for Aplidin® from the EMA PR Newswire
Jan-02-18 08:30AM  PharmaMar Signs a Commercialization and Distribution License Agreement for Aplidin® (plitidepsin) With Megapharm in Israel PR Newswire
Dec-15-17 03:02PM  Retail ETF Rise Ahead of a Robust Holiday Season Zacks
Dec-12-17 10:28AM  Plitidepsin (PharmaMar) Shows Activity Against the Cells Responsible for the Destruction of Bone in Myeloma Multiple PR Newswire
Dec-11-17 08:30AM  PharmaMar Presents Positive Results of the Pivotal Phase III Trial with Plitidepsin in Multiple Myeloma During the ASH Meeting PR Newswire
Nov-20-17 12:50PM  5 Retail ETFs to Buy for a Holiday-Shopping Boost InvestorPlace
Nov-15-17 08:30AM  Phase III Trial With Zepsyre® in Small-Cell Lung Cancer (ATLANTIS) to Continue on the Basis of Positive Recommendation by IDMC PR Newswire
Nov-14-17 08:30AM  PharmaMar to Present at the Stifel 2017 Healthcare Conference PR Newswire
Nov-13-17 08:30AM  PharmaMar Presents Positive Results from a Phase II Study of lurbinectedin in Ewing's Sarcoma at the CTOS International Congress PR Newswire
Nov-07-17 08:30AM  PharmaMar and Boryung Pharm Sign A Licensing Agreement for Zepsyre® (lurbinectedin) in Korea PR Newswire
Nov-04-17 08:30AM  PharmaMar Announces Partnership with 8th National Race to End Women's Cancer in Support of "End Women´s Cancer Weekend" in Washington D.C. PR Newswire
Oct-19-17 08:30AM  The World Health Organization Selects Tivanisiran as the International Nonproprietary Name for SYL1001 PR Newswire
Oct-18-17 08:30AM  Final Data on Phase I/II in Small-cell Lung Cancer with Zepsyre® Presented at the IASCLC 18th World Conference on Lung Cancer in Japan PR Newswire
Oct-10-17 08:30AM  PharmaMar Will Present Final Data on PM1183 During the 18th World Lung Conference in Japan PR Newswire
Oct-04-17 08:30AM  PharmaMar Submits the Marketing Authorisation Application for Aplidin® in Switzerland PR Newswire
Sep-25-17 11:37AM  Retail ETFs in Focus on Early Holiday Sales Forecast Zacks
08:30AM  PharmaMar: Sylentis Presents New Data on a New Eye Drop siRNA for the Treatment of Retinal Diseases Avoiding Intraocular Injections PR Newswire
Sep-20-17 08:30AM  PharmaMar Starts Clinical Studies with a New Compound -PM14- in Patients with Solid Tumors PR Newswire
03:30AM  PharmaMar Starts Clinical Studies with a New Compound -PM14- in Patients with Solid Tumors PR Newswire
Sep-18-17 11:15AM  A Look at Regency Centers Dividend Yield Market Realist
Sep-12-17 01:30PM  New Positive Data on PM1183 Sees a Response Rate of 36% as Single Agent in Patients With Advanced and Relapsed Small-Cell Lung Cancer PR Newswire
03:30AM  New Positive Data on PM1183 Sees a Response Rate of 36% as Single Agent in Patients With Advanced and Relapsed Small-Cell Lung Cancer PR Newswire
Aug-31-17 09:53AM  PharmaMar Will Present New Clinical Data on PM1183 During ESMO 2017 PR Newswire
Aug-09-17 08:30AM  PharmaMar Starts a Quadruple Combination Study With Aplidin® for the Treatment of Multiple Myeloma PR Newswire
Jul-07-17 06:08AM  The 5 Top Retail ETFs Motley Fool
Jun-20-17 09:00AM  FDA Chooses Zepsyre (PM1183) from PharmaMar to Explore Potential Development for Pediatric Cancers PR Newswire
Jun-19-17 02:43PM  Winners And Losers From Amazon's Purchase Of Whole Foods Benzinga
Jun-16-17 08:30AM  PharmaMar Will Commercialize PM1183 With the Trade Name of Zepsyre PR Newswire
Jun-13-17 05:00AM  PharmaMar Announces Encouraging Results in Clinical Trials of Lurbinectedin in Endometrial and Breast Cancers PR Newswire
Jun-01-17 09:00AM  Sylentis Initiates a Phase III Study for the Treatment of Dry Eye Syndrome PR Newswire
07:37AM  Ulta Beauty Stock Reacted Positively to Stellar 1Q17 Results Market Realist
May-26-17 01:50PM  Whats behind Costcos EPS Beat in Fiscal 3Q17? Market Realist
May-25-17 10:31AM  PharmaMar and Eczacba Sign a Licensing Agreement for Aplidin® in Turkey PR Newswire
May-19-17 09:00AM  PharmaMar Announces New Data with its Compounds Yondelis® and Lurbinectedin During ASCO 2017 PR Newswire
May-12-17 02:23PM  Retail ETF Returns Reflect Industry Upheaval
May-09-17 09:00AM  PharmaMar: Sylentis Announces New Preclinical and Clinical Data for its SYL1001 Molecule During ARVO 2017 PR Newswire
May-04-17 10:00AM  PharmaMar: Aplidin® Receives Orphan Drug Status for the Treatment of Multiple Myeloma in Switzerland PR Newswire
Apr-27-17 09:00AM  PharmaMar Demonstrates Its Progress in R&D in New York PR Newswire
Apr-24-17 08:00AM  PharmaMar to Host Research and Development Event today in New York PR Newswire
Apr-06-17 10:00AM  PharmaMar to Host Research and Development Event on April 24, 2017 PR Newswire
Apr-04-17 09:00AM  PharmaMar Presents New Data on the Treatment of Multiple myeloma and Ovarian Cancer at the AACR Congress PR Newswire
Mar-23-17 10:36AM  How Targets Valuation Looks Now Market Realist
09:07AM  Why Target Stock Has a Consensus Hold Rating Market Realist
Mar-22-17 05:05PM  Inside Targets Growth Initiatives Market Realist
03:36PM  How Targets Sales Are Trending Market Realist
01:42PM  Why Targets Stock Is Trading in the Red Market Realist
Mar-16-17 11:33AM  Consumer ETFs & Stocks Not Hurt by Soft February Retail Sales Zacks
Mar-03-17 10:33AM  Have Q4 Earnings Really Hurt Retail ETFs? Zacks
Feb-21-17 12:00PM  Retail Sales Rebound in January: ETF & Stock Picks Zacks
Feb-15-17 08:25AM  Retail ETFs in Trouble With No Q4 Surprise in Store
Jan-16-17 02:08PM  ETFs & Stocks Unfazed by Softer December Retail Sales
Jan-11-17 08:13AM  Why This Retail ETF Doubled Its Assets In A Week
Dec-22-16 03:24AM  PharmaMar and Chugai Pharmaceutical Enter into a License and Commercialization Agreement for PM1183 in Japan PR Newswire
Dec-16-16 09:19AM  5 Top-Ranked Consumer Discretionary ETFs to Buy Now
Dec-01-16 02:26PM  Holiday Shopping Not A Gift For All Retail ETFs
03:00AM  PharmaMar Presents Positive Results With Its Conjugated Antibody MI130110 in CD13-Expressing Tumor-Cells PR Newswire
Nov-29-16 10:13AM  4 Reasons to Buy Retail ETFs This Holiday Season
Nov-28-16 09:05AM  PharmaMar Begins a Phase I Study of PM1183 in Japan for the Treatment of Solid Tumors PR Newswire
Nov-25-16 09:38AM  Big Day for Retailers: 5 ETFs to Shop for Black Friday
Nov-23-16 12:03PM  Retail ETF Deals You Should Not Miss on Black Friday
06:17AM  This online retail ETF is already an outperformer ahead of Black Friday at MarketWatch
Nov-16-16 10:57AM  Retail Sales Sustain Winning Momentum: ETF & Stock Bets
08:45AM  PharmaMar Appoints Pascal Besman as Chief Operating Officer of PharmaMar U.S. PR Newswire
Nov-15-16 09:45AM  How Are Retail ETFs Shaping up For Q3 Earnings?
Nov-14-16 10:40AM  3 ETFs to Buy if You Think TJX Will Beat on Earnings
Nov-08-16 12:08PM  CVS Drops 12%; Retail ETFs Get A Ride at
09:20AM  3 ETFs to Buy on CVS Earnings
Oct-31-16 05:00AM  PharmaMar is Present at the 16th International Gynecologic Cancer Society Meeting With New Evidence on Yondelis® PR Newswire
Oct-28-16 08:45AM  The EMA Accepts to Assess the Marketing Authorization Application from PharmaMar for Aplidin® PR Newswire
Oct-26-16 01:57PM  4 ETFs & Stocks to Treat You on Halloween and After
Oct-24-16 03:00AM  PharmaMar Announces the Opening of a New Affiliate in Austria PR Newswire
Oct-18-16 09:00AM  PharmaMar Completes the Patient Recruitment for the "CORAIL" Phase III Pivotal Study With PM1183 PR Newswire
Oct-10-16 09:00AM  PharmaMar Announces Positive Results From its Phase II Study With lurbinectedin in BRCA 1/2 - Associated Metastatic Breast Cancer at the ESMO 2016 Congress PR Newswire
Oct-07-16 01:16PM  Is the Dividend ETF Bull Run Over?
Oct-05-16 09:42AM  3 ETFs to Buy for a Media Merger Frenzy
09:00AM  PharmaMar Shows New Clinical Data on Yondelis® and Lurbinectedin at ESMO 2016 PR Newswire
Oct-04-16 09:00AM  PharmaMar and Boryung Pharm Sign a Licensing Agreement for Aplidin® (plitidepsin) in Korea PR Newswire
Sep-22-16 09:00AM  PharmaMar Submits MAA to EMA for Aplidin® for the Treatment of Multiple Myeloma PR Newswire
Sep-01-16 11:04AM  How Are Eli Lillys Business Segments Performing?
Aug-24-16 10:04AM  Why Did Hormel Foods Increase Its Fiscal 2016 Guidance?
Aug-23-16 09:30AM  The Zacks Analyst Blog Highlights: PureFunds ISE Junior Silver ETF, SPDR S&P Technology Hardware ETF, PowerShares Dynamic Semiconductors ETF, SPDR S&P Health Care Services ETF and PowerShares DWA Utilities Momentum ETF
Aug-11-16 04:00AM  PharmaMar Announces the IDMC´s Response on the CORAIL Trial Using PM1183 PR Newswire
Aug-04-16 09:47AM  Top Tech ETFs Of 2016
Aug-02-16 04:00AM  PharmaMar Initiates a Pivotal Phase III ATLANTIS Study with PM1183 in Combination with Doxorubicin in Patients with Small Cell Lung Cancer PR Newswire
Jul-27-16 11:57AM  This Seasonal ETF Is Ripe For The Pickin' This Summer
The investment seeks to track the investment results (before fees and expenses) of the Dynamic Retail IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of retail companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. retailers. These companies are engaged principally in operating general merchandise stores such as department stores, discount stores, warehouse clubs and superstores; specialty stores, including apparel, electronics, accessories and footwear stores; and home improvement and home furnishings stores. It is non-diversified.